1. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
2. |
Vagianos C, Karavias D, Dragotis C, et al. Obstructive jaundice due to intracholedochal blood clot: an unusual early presentation of primary hepatic carcinoma. Br J Clin Pract, 1993, 47(4): 222-223.
|
3. |
Wu L, Wu J, Zhang H. Hypoglycemia-induced convulsive status epilepticus as the initial presentation of primary hepatic carcinoma. Neurol Sci, 2012, 33(6): 1469-1471.
|
4. |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范 (2017 年版). 中华肝脏病杂志, 2017, 25(12): 886-895.
|
5. |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
|
6. |
梁睿, 翟溯澜, 王柳燕, 等. 白藜芦醇调控 miR-519c 逆转乳腺癌多柔比星耐药作用机制研究. 中华肿瘤防治杂志, 2019, 26(15): 1066-1071.
|
7. |
苗向霞, 郭蕊, 张璎, 等. 白藜芦醇对肝癌 HepG2 细胞中脂肪合成的抑制作用及其机制. 吉林大学学报: 医学版, 2019, 45(1): 69-72.
|
8. |
赵宇, 祝瑜, 吴浪, 等. 白藜芦醇对人肝癌 HepG2 细胞增殖及自噬作用的影响. 中国生物制品学杂志, 2018, 31(6): 607-612.
|
9. |
Rauf A, Imran M, Suleria HAR, et al. A comprehensive review of the health perspectives of resveratrol. Food Funct, 2017, 8(12): 4284-4305.
|
10. |
Kovacic P, Somanathan R. Multifaceted approach to resveratrol bioactivity: focus on antioxidant action, cell signaling and safety. Oxid Med Cell Longev, 2010, 3(2): 86-100.
|
11. |
Venturini CD, Merlo S, Souto AA, et al. Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes. Oxid Med Cell Longev, 2010, 3(6): 434-441.
|
12. |
Kundu JK, Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett, 2008, 269(2): 243-261.
|
13. |
林春蕾, 何磊, 王凡, 等. 白藜芦醇的肝脏药理作用. 现代生物医学进展, 2013, 13(26): 5162-5164.
|
14. |
胜利, 安利峰, 李覃, 等. 白藜芦醇抗肿瘤作用的研究进展. 医学综述, 2005, 11(7): 605-606.
|
15. |
张兰胜, 刘光明. 白藜芦醇的研究概述. 大理学院学报, 2007, 6(4): 72-74, 80.
|
16. |
闫静, 王振月, 刘丹宁, 等. 白藜芦醇及其甙的生物活性研究进展. 中医药学报, 2000, (2): 39-41.
|
17. |
付招娣, 曹玉, 王凯风, 等. 白藜芦醇对癌的化学预防作用. 癌症, 2004, 23(8): 869-873.
|
18. |
Delmas D, Rébé C, Lacour S, et al. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem, 2003, 278(42): 41482-41490.
|
19. |
Bishayee A, Barnes KF, Bhatia D, et al. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev Res (Phila), 2010, 3(6): 753-763.
|
20. |
朱青, 张王刚, 王立锋, 等. 白藜芦醇诱导肿瘤细胞凋亡和细胞周期阻滞的作用及机制. 医学争鸣, 2005, 26(21): 1935-1937.
|
21. |
Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene, 2008, 27(41): 5497-5510.
|
22. |
王晓辉, 李非, 郑亚民, 等. caveolin-1 通过阻断 PI3K/Akt 信号的激活抑制胰腺癌细胞增殖. 中国普外基础与临床杂志, 2011, 18(10): 1054-1059.
|
23. |
Alkhalaf M. Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells. Pharmacology, 2007, 80(2-3): 134-143.
|
24. |
Zhang Y, Chen ML, Zhou Y, et al. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway. Mol Nutr Food Res, 2015, 59(8): 1443-1457.
|
25. |
Pozo-Guisado E, Lorenzo-Benayas MJ, Fernández-Salguero PM. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer, 2004, 109(2): 167-173.
|
26. |
孙中杰, 余海波, 张煜, 等. 白藜芦醇对裸鼠移植性肝癌的抑制作用. 陕西医学杂志, 2010, 39(3): 279-281.
|